Evidence map›Paper›PMID 38465211›Full record

ArticleJournal of ginseng research2024

Hongyan Nie, Hongxin Liao, Jinrui Wen, Cuiqiong Ling, Liyan Zhang, Furong Xu, Xian Dong

Abstract read
In one paragraph

Article in Journal of ginseng research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Genome-Wide Identification of Histone Acetyltransferases inJournal of fungi (Basel, Switzerland) · 2026
    Article
  3. Review
  4. Exploring theJournal of ginseng research · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Menthone lowers H3K27ac levels to inhibitFrontiers in microbiology · 2025
    Article
  9. Article
  10. Environmentally Friendly Microemulsions of Essential Oils ofNanomaterials (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hongyan NieSchool of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming, China.
Hongxin LiaoSchool of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming, China.
Jinrui WenSchool of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming, China.
Cuiqiong LingSchool of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming, China.
Liyan ZhangSchool of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming, China.
Furong XuSchool of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming, China.
Xian DongSchool of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: In this study, we prepared and characterized a nanoemulsion of Results: Results showed that the minimum inhibitory concentration (MIC) of Ne-FvEO decreased from 3.65 mg/mL to 0.35 mg/mL, and its bioavailability increased by 10-fold. The results of gas chromatography/mass spectrometry (GC/MS) showed that T-FvEO did not contain a high content of estragole compared to Conclusion: Our findings suggest that Ne-FvEO effectively inhibited the growth of

Indexed as

Antifungal mechanismMetabolomeNanoemulsionNatural productTranscriptome

Identifiers

PMID38465211
PMCPMC10920008

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.